Acadia Pharmaceuticals (ACAD) Cash from Operations Growth (5y) (2015 - 2026)
Acadia Pharmaceuticals (ACAD) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Acadia Pharmaceuticals |
3.68 Bn |
2.83 Bn |
243.27 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
20.73% |
| Dec 31, 2025 |
-12.13% |
| Sep 30, 2025 |
39.37% |
| Jun 30, 2025 |
30.15% |
| Mar 31, 2025 |
19.28% |
| Dec 31, 2024 |
27.42% |
| Sep 30, 2024 |
39.88% |
| Jun 30, 2024 |
21.53% |
| Mar 31, 2024 |
19.66% |
| Dec 31, 2023 |
33.15% |
| Sep 30, 2023 |
-6.88% |
| Jun 30, 2023 |
17.09% |
| Mar 31, 2023 |
16.89% |
| Dec 31, 2022 |
4.41% |
| Sep 30, 2022 |
58.41% |
| Jun 30, 2022 |
25.94% |
| Mar 31, 2022 |
-1.58% |
| Dec 31, 2021 |
17.69% |
| Sep 30, 2021 |
19.11% |
| Jun 30, 2021 |
14.90% |
